WordNet

of or relating to infection; "infectious hospital"; "infectious disease"
caused by infection or capable of causing infection; "viruses and other infective agents"; "a carrier remains infective without himself showing signs of the disease" (同)infective
easily spread; "fear is exceedingly infectious; children catch it from their elders"- Bertrand Russell
a harmful or corrupting agency; "bigotry is a virus that must not be allowed to spread"; "the virus of jealousy is latent in everyone"
(virology) ultramicroscopic infectious agent that replicates itself only within cells of living hosts; many are pathogenic; a piece of nucleic acid (DNA or RNA) wrapped in a thin coat of protein
a software program capable of reproducing itself and usually capable of causing great harm to files or other programs on the same computer; "a true virus cannot spread to another computer without human assistance" (同)computer virus
inflammation of the liver caused by a virus or a toxin

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. B型肝炎のマネージメントの概要および症例 overview of the management of hepatitis b and case examples
2. 成人におけるA型肝炎ウイルス感染の概要 overview of hepatitis a virus infection in adults
3. 肝炎ウイルスと新生児：臨床症状および治療 hepatitis viruses and the newborn clinical manifestations and treatment
4. E型肝炎ウイルス感染 hepatitis e virus infection
5. 小児および思春期におけるB型肝炎ウイルス感染の概要 overview of hepatitis b virus infection in children and adolescents

Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience.

Waldenström J1, Färkkilä M2, Rembeck K1, Norkrans G1, Langeland N3,4, Mørch K4, Pedersen C5, Rauning Buhl M6, Nieminen U2, Nuutinen H2, Alsiö Å7, Holmström L8, Jungnelius R9, Lund K10, Rubensson A11, Torell E12, Westin J1, Lagging M1.
Scandinavian journal of gastroenterology.Scand J Gastroenterol.2016 Mar;51(3):337-43. doi: 10.3109/00365521.2015.1087588. Epub 2015 Sep 29.
OBJECTIVE: Interferon-free therapy for hepatitis C virus (HCV) infection is costly, and therefore patients with advanced fibrosis are prioritized. Although coupled with considerable side effects, a large proportion of genotype 2/3 infected patients achieve a sustained virological response (SVR) foll
PMID 26418670

Vaghi V1, Potrich C2, Pasquardini L1, Lunelli L3, Vanzetti L4, Ebranati E5, Lai A5, Zehender G5, Mombello D6, Cocuzza M7, Pirri CF8, Pederzolli C1.
Biophysical chemistry.Biophys Chem.2016 Jan;208:54-61. doi: 10.1016/j.bpc.2015.06.005. Epub 2015 Jun 11.
Hepatitis C virus (HCV) is one of the main causes of chronic liver disease worldwide. The diagnosis and monitoring of HCV infection is a crucial need in the clinical management. The conventional diagnostic technologies are challenged when trying to address molecular diagnostics, especially because t
PMID 26091724

Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?

Nicolini LA1, Menzaghi B, Ricci E, Martinelli C, Magni C, Maggi P, Celesia BM, Parruti G, Babudieri S, Bonfanti P, Falasca K, Vichi F, De Socio GV, Salomoni E, Di Biagio A, Quirino T.
European journal of gastroenterology & hepatology.Eur J Gastroenterol Hepatol.2016 Jan;28(1):37-41. doi: 10.1097/MEG.0000000000000483.
OBJECTIVE: HIV/hepatitis C virus (HCV) coinfected patients are usually considered a difficult-to-treat population. The aim of this study was to assess the effectiveness of telaprevir-based and boceprevir-based treatments with respect to the HIV status.METHODS: A prospective multicentre study was con
PMID 26460621